Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01175980 · OUTCOME

Unique Probes on the Oligonucleotide CGH Array as a Measure of the Genomic Profile of Each Cell Population.

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma · Source last updated 2020-08-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
unique probes on the CGH arrays
Interval / dispersion
Not reported
Time frame
Up to 180 days after the last dose of vorinostat maximum treatment duration= 24 months

What was measured

Genomic profile of each cell population using oligonucleotide CGH arrays. Reported as unique probes on the CGH array.

Analysis population: One of the cases that had FFPE blocks for the study.

Groups in this outcome

Treatment (Vorinostat)

Patients receive vorinostat PO QD on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Vorinostat: Given PO

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Vorinostat)1

Reported measurements

Source class 1
Values in unique probes on the CGH arrays · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Treatment (Vorinostat)442,892Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        442,892
denoms
  1. counts
    1. group Id
      OG000
      value
      1
    units
    Participants
description
Genomic profile of each cell population using oligonucleotide CGH arrays. Reported as unique probes on the CGH array.
groups
  1. description
    Patients receive vorinostat PO QD on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Vorinostat: Given PO
    id
    OG000
    title
    Treatment (Vorinostat)
param Type
NUMBER
population Description
One of the cases that had FFPE blocks for the study.
reporting Status
POSTED
time Frame
Up to 180 days after the last dose of vorinostat maximum treatment duration= 24 months
title
Unique Probes on the Oligonucleotide CGH Array as a Measure of the Genomic Profile of Each Cell Population.
type
OTHER_PRE_SPECIFIED
unit Of Measure
unique probes on the CGH arrays

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice